Edgar Filing: CLINICAL DATA INC

Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Â FOREST LABORATORIES INC

2. Date of Event Requiring Statement (Month/Day/Year)
02/22/2011

3. Issuer Name and Ticker or Trading Symbol
CLINICAL DATA INC [CLDA]

(Last)

(First)

(Middle)

909 THIRD AVENUE,Â

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	__X__ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

NEW YORK,Â NYÂ 10022

6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	0 ⁽¹⁾ ⁽²⁾	I ⁽¹⁾ ⁽²⁾	See Footnotes ⁽¹⁾ ⁽²⁾

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
2017 Convertible Notes	02/25/2009⁽³⁾	02/25/2017⁽⁴⁾	Common Stock	0 ⁽¹⁾ ⁽²⁾	$ 8.1825	I ⁽¹⁾ ⁽²⁾	See Footnotes ⁽¹⁾ ⁽²⁾
2005 Warrants	11/17/2005	05/17/2011	Common Stock	0 ⁽¹⁾ ⁽²⁾	$ 15.6	I ⁽¹⁾ ⁽²⁾	See Footnotes ⁽¹⁾ ⁽²⁾
2008 Warrants	09/26/2008	03/26/2014	Common Stock	0 ⁽¹⁾ ⁽²⁾	$ 16.44	I ⁽¹⁾ ⁽²⁾	See Footnotes ⁽¹⁾ ⁽²⁾
2009 Warrants	02/25/2009	08/25/2014	Common Stock	0 ⁽¹⁾ ⁽²⁾	$ 8.12	I ⁽¹⁾ ⁽²⁾	See Footnotes ⁽¹⁾ ⁽²⁾
2009 Warrants	02/25/2009	08/25/2014	Common Stock	0 ⁽¹⁾ ⁽²⁾	$ 9.744	I ⁽¹⁾ ⁽²⁾	See Footnotes ⁽¹⁾ ⁽²⁾

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
FOREST LABORATORIES INC 909 THIRD AVENUE NEW YORK,Â NYÂ 10022	Â	Â X	Â	Â
FL Holding C.V. C/O FOREST LABORATORIES, INC. 909 THIRD AVENUE NEW YORK,Â NYÂ 10022	Â	Â	Â Manager	Â
FLI International, LLC C/O FOREST LABORATORIES, INC. 909 THIRD AVENUE NEW YORK,Â NYÂ 10022	Â	Â	Â Vice President	Â
Magnolia Acquisition Corp. C/O FOREST LABORATORIES, INC. 909 THIRD AVENUE NEW YORK,Â NYÂ 10022	Â	Â	Â Vice President	Â

Signatures

/s/ Herschel S. Weinstein, Vice President and General Counsel of Forest Laboratories, Inc.		03/04/2011
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Solely for purposes of determining whether a person is a beneficial owner of more than ten percent (a "ten percent owner") of any class of equity securities registered pursuant to section 12 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), Rule 16a-1 under the Exchange Act ("Rule 16a-1") provides that the term "beneficial owner" shall mean any person who is deemed a beneficial owner pursuant to Section 13(d) of the Exchange Act and the rules thereunder. Rule 13d-3 under the Exchange Act ("Rule 13d-3"), in turn, provides that a person will be deemed to beneficially own all securities over which such person (i) has voting or investment control or (ii) may acquire voting or investment control within 60 days of the date of determination. (Continued in Footnote 2)
(2)	For reporting purposes, however, Rule 16a-2 under the Exchange Act ("Rule 16a-2") provides that a person is only deemed to be the beneficial owner of securities if that person has or shares the opportunity, directly or indirectly, to profit or share in any profit derived from a transaction in such securities (a "pecuniary interest"). However, none of the Forest Entities have any pecuniary interest in the Subject Securities (as defined below) and therefore, in accordance with Rule 16a-2, they are not deemed to beneficially own any of the Subject Securities.
(3)	The 2017 Convertible Notes may be repaid at any time upon 90 days prior notice.
(4)	The final maturity date of the 2017 Convertible Notes is February 25, 2017.
Â Remarks: ThisÂ formÂ isÂ filedÂ onÂ behalfÂ ofÂ ForestÂ Laboratories,Â Inc.Â ("Forest"),Â FLÂ HoldingÂ C.V.Â ("FLÂ Holding"),Â FLIÂ InternationalÂ LLCÂ ("FLIÂ International")Â andÂ MagnoliaÂ AcquisitionÂ Corp.Â ("Magnolia",Â andÂ togetherÂ withÂ Forest,Â FLÂ HoldingÂ andÂ FLIÂ International,Â theÂ "ForestÂ Entities"Â andÂ eachÂ aÂ "ForestÂ Entity"),Â allÂ ofÂ whichÂ areÂ filingÂ asÂ membersÂ ofÂ aÂ 10%Â ownerÂ group.Â Â ForestÂ isÂ theÂ directÂ parentÂ ofÂ FLÂ Holding,Â andÂ theÂ indirectÂ parentÂ ofÂ FLIÂ InternationalÂ andÂ Magnolia.Â Â FLÂ HoldingÂ isÂ theÂ parentÂ ofÂ Magnolia,Â andÂ FLIÂ InternationalÂ isÂ theÂ generalÂ partnerÂ ofÂ FLÂ Holding.Â Â TheÂ principalÂ businessÂ addressÂ ofÂ ForestÂ isÂ ForestÂ Laboratories,Â Inc.,Â 909Â ThirdÂ Avenue,Â NewÂ York,Â NewÂ YorkÂ 10019.Â Â TheÂ principalÂ businessÂ addressÂ ofÂ eachÂ ofÂ FLIÂ InternationalÂ andÂ MagnoliaÂ isÂ c/oÂ ForestÂ Laboratories,Â Inc.,Â 909Â ThirdÂ Avenue,Â NewÂ York,Â NewÂ YorkÂ 10019.Â Â TheÂ principalÂ businessÂ addressÂ ofÂ FLÂ HoldingÂ isÂ CoxÂ HallettÂ Wilkson,Â CumberlandÂ House,Â 1Â VictoriaÂ Street,Â 9thÂ Floor,Â Hamilton,Â BermudaÂ HM11.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.